Shareholders Equity: The sum of preferred and common equity items.
Avadel Pharmaceuticals PLC. (AVDL) had Shareholders Equity of $98.22M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$77.47M |
|
$0.02M |
|
$-4.12M |
|
$81.58M |
|
$75.53M |
|
$1.94M |
|
$-1.88M |
|
$0.05M |
|
$0.05M |
|
$0.02M |
|
$0.02M |
|
$0.02M |
|
$0.02M |
|
$1.94M |
|
$3.05M |
|
97.10M |
|
101.28M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$172.23M |
|
$0.47M |
|
$27.22M |
|
$199.45M |
|
$62.49M |
|
-- |
|
$38.74M |
|
$101.22M |
|
$98.22M |
|
$81.39M |
|
|
Shareholders Equity |
$98.22M |
97.33M |
|
| Cash Flow Statement Financials | |
$26.67M |
|
$-4.37M |
|
$4.18M |
|
$51.37M |
|
$79.81M |
|
$28.44M |
|
$14.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
105.31% |
|
2.50% |
|
2.50% |
|
-- |
|
0.07% |
|
0.03% |
|
$26.48M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
-0.17 |
|
1.83 |
|
49.31 |
|
0.02% |
|
0.02% |
|
0.01% |
|
0.02% |
|
$1.01 |
|
$0.26 |
|
$0.26 |
|